Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | 9 Months Ended |
|---|---|---|---|
Aug. 31, 2024 |
Mar. 31, 2025 |
Mar. 31, 2025 |
|
| Deferred Compensation Arrangement with Individual, Share-Based Payments [Line Items] | |||
| Number of expired vested stock options (in shares) | 791,204 | ||
| Litigation charges | $ 38.9 | $ 40.6 | |
| Former CEO | |||
| Deferred Compensation Arrangement with Individual, Share-Based Payments [Line Items] | |||
| Payment for settlement of litigation | 37.2 | ||
| Number of expired vested stock options covered in first settlement payment (in shares) | 779,084 | ||
| Former employees excluding former CEO | |||
| Deferred Compensation Arrangement with Individual, Share-Based Payments [Line Items] | |||
| Payment for settlement of litigation | $ 0.5 | ||
| Number of expired vested stock options covered in first settlement payment (in shares) | 12,120 |
| X | ||||||||||
- Definition Number of expired options covered in the first settlement payment. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|